Amplifon’s 5.3% drop: cautious entry, not a clear capitulation

I would not attribute today’s −5.29% move to any particular cause; the data don’t tell us one. It extends an existing weak trend: shares are down 17.9% over 12 months and 18.4% below their 52-week high. The price is not obviously cheap on trailing earnings at 38.2x, but consensus puts 2026 and 2027 P/E at 16.7x and 12.9x, alongside estimated EPS growth of 29.5% in 2027. That recovery is uncertain: Q4 and Q1 EPS estimates imply year-on-year declines of 24.8% and 55.2%. Q3’s 1.6% net margin and debt/equity of 1.16 temper the case; the 2.5% dividend yield is less reassuring with a 93% payout. The drop doesn’t change my view: I’ll start small, not call it a deep-value bargain.